Cancer BiologybioRxivPreprint
ALK/ATR combination therapy is effective in neuroblastoma mouse tumors driven by MYCN
Marcus Borenäs, Dan Emil Lind, Adam Lehnberg…·Ruth Helen Palmer
This study shows that combining ATR and ALK inhibitors improves survival in MYCN-amplified neuroblastoma mouse models lacking ALK mutations.
1 citation